Privia Health Group (PRVA) 43rd Annual J.P. Morgan Healthcare Conference 2025 summary

Business model and strategy

• Operates in 14 states plus D.C., partnering with over 4,600 providers at 1,170+ care centers, serving over 5.1 million patients, with 1.2 million in value-based arrangements and a 98% gross provider retention rate.

• Establishes multi-specialty medical groups, risk-bearing entities, and an integrated tech/services platform in each state, supporting physician-led governance.

• Employs a full-solution physician alignment model, balancing growth, profitability, and capital efficiency, with diversified FFS and VBC contracts.

• Drives growth by transitioning practices to value-based care across commercial, Medicare, and Medicaid lines.

• Enables providers to remain autonomous while improving profitability and care quality.

Technology and operational execution

• Utilizes a cloud-based ERP platform, integrating 30+ point solutions to optimize care delivery and reimbursement.

• Deeply integrates into provider workflows, enabling efficient transitions to advanced risk models.

• Manages $8.9B–$9B in medical spend across 100+ value-based programs, emphasizing risk diversification and robust oversight.

• Delivers superior unit economics: customer acquisition costs down 38–40% since 2018, platform contribution per provider up 30%+, payback period reduced to 0.9 years, and LTV/CAC ratio at 22.5.

• Comprehensive tech and services platform reduces administrative burden for providers.

Financial performance and outlook

• Achieved 13.1% YoY growth in implemented providers and 14.0% growth in attributed lives in Q3 2024, with practice collections up 2.3% to $739.9M.

• YTD 2024 practice collections reached $2.18B (+4.5%), care margin $296.1M (+10.6%), and adjusted EBITDA $65.6M (+19.3%).

• Maintains a strong balance sheet with ~$475M in cash and no debt at Q3 end; YTD pro forma free cash flow at $87.0M.

• Consistently converts 100% of EBITDA to free cash flow over six years, with nearly zero CapEx.

• Reiterates 2024 guidance: practice collections $2.775B–$2.875B, care margin $388M–$400M, adjusted EBITDA $85M–$90M, and attributed lives above 1.2M.